Fig. 3From: Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assayDistribution of PTEN methylation degree among breast cancer patients according to tumor (a) stages, (b) grades, (c) lymph node, (d) estrogen receptor, (e) progesterone receptor, and (f) HER2 statuses. Significant difference was determined using Student’s t test. P value < 0.05 was considered significantBack to article page